Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Scientific References Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
For 1 year, half of the study participants were administered a dose of liraglutide while the other half received a placebo
Additionally, research suggests the percentage of participants on Zepbound achieving more than 10% weight loss is considerably higher than Wegovy
Presented for research literature review only Greig C et al
US$ 28.03
US$ 29.07
US$ 23.82
US$ 22.77
.png)
US$ 20.26
US$ 29.35
US$ 27.46
